MAZE (Maze Therapeutics, Inc.) Stock Financials & Earnings | Market Cap Arena

MAZE (Maze Therapeutics, Inc.) Stock Financials & Earnings | Market Cap Arena

MAZEMaze Therapeutics, Inc.

Mkt Cap$2B

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$0

Net Income (TTM)-$126M

EPS (TTM)-$2.29

Free Cash Flow (TTM)-$108M

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth-100.0%

Employees—

Earnings Reports

Next: Q4 2025 · Mar 12

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q3 23	$0	$0	-$25M
Q4 23	$0	$0	-$23M
Q1 24	$0	$0	-$28M
Q2 24	$165M	$165M	$140M
Q3 24	$3M	$3M	-$24M
Q4 24	$0	$0	-$30M
Q1 25	$0	$0	-$35M
Q2 25	$0	-$649K	-$36M
Q3 25	$0	$0	-$33M

Valuation

Quarter	P/S	P/E
Q3 23	—	—
Q4 23	—	—
Q1 24	—	—
Q2 24	14.0x	42.0x
Q3 24	13.8x	42.0x
Q4 24	13.8x	44.4x
Q1 25	13.8x	44.6x
Q2 25	927.2x	—
Q3 25	—	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q3 23	-$20M	-$20M
Q4 23	-$21M	-$21M
Q1 24	-$23M	-$24M
Q2 24	$145M	$145M
Q3 24	-$23M	-$23M
Q4 24	-$22M	-$23M
Q1 25	-$30M	-$30M
Q2 25	-$30M	-$30M
Q3 25	-$25M	-$25M

Capital Expenditures

CapEx

Quarter	CapEx
Q3 23	$3K
Q4 23	$34K
Q1 24	$279K
Q2 24	$160K
Q3 24	$103K
Q4 24	$605K
Q1 25	$299K
Q2 25	$393K
Q3 25	$68K

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q3 24	—	+5.9%
Q4 24	—	+29.0%
Q1 25	—	+26.4%
Q2 25	-100.0%	+43.3%
Q3 25	-100.0%	+23.3%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q3 23	$2M	—
Q4 23	$3M	—
Q1 24	$2M	—
Q2 24	$2M	1.3%
Q3 24	$2M	93.7%
Q4 24	$3M	—
Q1 25	$3M	—
Q2 25	$3M	—
Q3 25	$4M	—

OpEx Breakdown

Quarter	R&D	G&A
Q3 23	$19M	$6M
Q4 23	$16M	$7M
Q1 24	$22M	$6M
Q2 24	$20M	$6M
Q3 24	$20M	$7M
Q4 24	$22M	$8M
Q1 25	$28M	$8M
Q2 25	$28M	$8M
Q3 25	$25M	$8M

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 23	$29M	$0	$29M
Q2 24	$175M	$0	$175M
Q3 24	$150M	$0	$150M
Q4 24	$197M	$0	$197M
Q1 25	$294M	$0	$294M
Q2 25	$265M	$0	$265M
Q3 25	$317M	$67M	$384M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q3 23	44M	—
Q4 23	44M	+0.0%
Q1 24	44M	+0.0%
Q2 24	44M	-0.0%
Q3 24	44M	-0.0%
Q4 24	44M	+0.0%
Q1 25	44M	+0.0%
Q2 25	44M	+0.1%
Q3 25	46M	+4.4%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 22	—	—
FY 23	—	—
FY 24	$12K	14K